ANNALS OF HEMATOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：投白血病相关的综述，2个审稿人，提的意见比较中肯，审稿速度很快 2023-11-23 投稿 2023-11-28 editor assigned 2023-11-29 Under Review 2023-12-12 Major revision 2023-12-26 Submitted to journal 2023-12-27 Under Review 2024-01-15 minor revision 2024-01-16 Submitted to journal 2024-01-19 Submission accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2020-09-04 投稿 2020-09-10 with editor 2020-10-02 Under Review 2020-11-11 Major Revision 2021-02-01 大修返回去 2021-02-02 with editor 2021-02-24 Accept 两个审稿人，大约提了20个问题，许多都是我们当时刻意回避的，审稿人都提出来了，在大修中认真回答审稿人的问题，让做亚组分析就做亚组分析，不能补充的内容就实话实说，告知审稿人我们的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2024-04-11 2606467171 来自四川省

质量检查就10天了，崩溃

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：投白血病相关的综述，2个审稿人，提的意见比较中肯，审稿速度很快 2023-11-23 投稿 2023-11-28 editor assigned 2023-11-29 Under Review 2023-12-12 Major revision 2023-12-26 Submitted to journal 2023-12-27 Under Review 2024-01-15 minor revision 2024-01-16 Submitted to journal 2024-01-19 Submission accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2020-09-04 投稿 2020-09-10 with editor 2020-10-02 Under Review 2020-11-11 Major Revision 2021-02-01 大修返回去 2021-02-02 with editor 2021-02-24 Accept 两个审稿人，大约提了20个问题，许多都是我们当时刻意回避的，审稿人都提出来了，在大修中认真回答审稿人的问题，让做亚组分析就做亚组分析，不能补充的内容就实话实说，告知审稿人我们的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2024-01-24 ms8000000428100640 来自四川省

审稿速度:2.0 | 投稿命中率:75.0
经验分享：投白血病相关的综述，2个审稿人，提的意见比较中肯，审稿速度很快
2023-11-23 投稿
2023-11-28 editor assigned
2023-11-29 Under Review
2023-12-12 Major revision
2023-12-26 Submitted to journal
2023-12-27 Under Review
2024-01-15 minor revision
2024-01-16 Submitted to journal
2024-01-19 Submission accepted

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：投白血病相关的综述，2个审稿人，提的意见比较中肯，审稿速度很快 2023-11-23 投稿 2023-11-28 editor assigned 2023-11-29 Under Review 2023-12-12 Major revision 2023-12-26 Submitted to journal 2023-12-27 Under Review 2024-01-15 minor revision 2024-01-16 Submitted to journal 2024-01-19 Submission accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2020-09-04 投稿 2020-09-10 with editor 2020-10-02 Under Review 2020-11-11 Major Revision 2021-02-01 大修返回去 2021-02-02 with editor 2021-02-24 Accept 两个审稿人，大约提了20个问题，许多都是我们当时刻意回避的，审稿人都提出来了，在大修中认真回答审稿人的问题，让做亚组分析就做亚组分析，不能补充的内容就实话实说，告知审稿人我们的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2023-10-21 清清欢来自江西省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;血液病
经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted

94 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：投白血病相关的综述，2个审稿人，提的意见比较中肯，审稿速度很快 2023-11-23 投稿 2023-11-28 editor assigned 2023-11-29 Under Review 2023-12-12 Major revision 2023-12-26 Submitted to journal 2023-12-27 Under Review 2024-01-15 minor revision 2024-01-16 Submitted to journal 2024-01-19 Submission accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2020-09-04 投稿 2020-09-10 with editor 2020-10-02 Under Review 2020-11-11 Major Revision 2021-02-01 大修返回去 2021-02-02 with editor 2021-02-24 Accept 两个审稿人，大约提了20个问题，许多都是我们当时刻意回避的，审稿人都提出来了，在大修中认真回答审稿人的问题，让做亚组分析就做亚组分析，不能补充的内容就实话实说，告知审稿人我们的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2023-04-13 凶巴巴恰北北怪兽

2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气

70 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：投白血病相关的综述，2个审稿人，提的意见比较中肯，审稿速度很快 2023-11-23 投稿 2023-11-28 editor assigned 2023-11-29 Under Review 2023-12-12 Major revision 2023-12-26 Submitted to journal 2023-12-27 Under Review 2024-01-15 minor revision 2024-01-16 Submitted to journal 2024-01-19 Submission accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2020-09-04 投稿 2020-09-10 with editor 2020-10-02 Under Review 2020-11-11 Major Revision 2021-02-01 大修返回去 2021-02-02 with editor 2021-02-24 Accept 两个审稿人，大约提了20个问题，许多都是我们当时刻意回避的，审稿人都提出来了，在大修中认真回答审稿人的问题，让做亚组分析就做亚组分析，不能补充的内容就实话实说，告知审稿人我们的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2021-02-24 bright120

审稿速度:2.0 | 投稿命中率:50.0
经验分享：2020-09-04 投稿
2020-09-10 with editor
2020-10-02 Under Review
2020-11-11 Major Revision
2021-02-01 大修返回去
2021-02-02 with editor
2021-02-24 Accept
两个审稿人，大约提了20个问题，许多都是我们当时刻意回避的，审稿人都提出来了，在大修中认真回答审稿人的问题，让做亚组分析就做亚组分析，不能补充的内容就实话实说，告知审稿人我们的困难。

216 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：投白血病相关的综述，2个审稿人，提的意见比较中肯，审稿速度很快 2023-11-23 投稿 2023-11-28 editor assigned 2023-11-29 Under Review 2023-12-12 Major revision 2023-12-26 Submitted to journal 2023-12-27 Under Review 2024-01-15 minor revision 2024-01-16 Submitted to journal 2024-01-19 Submission accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2020-09-04 投稿 2020-09-10 with editor 2020-10-02 Under Review 2020-11-11 Major Revision 2021-02-01 大修返回去 2021-02-02 with editor 2021-02-24 Accept 两个审稿人，大约提了20个问题，许多都是我们当时刻意回避的，审稿人都提出来了，在大修中认真回答审稿人的问题，让做亚组分析就做亚组分析，不能补充的内容就实话实说，告知审稿人我们的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2019-08-13 122e6881m72暂无昵称

三个月了，一审还在under review。。。

113 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：投白血病相关的综述，2个审稿人，提的意见比较中肯，审稿速度很快 2023-11-23 投稿 2023-11-28 editor assigned 2023-11-29 Under Review 2023-12-12 Major revision 2023-12-26 Submitted to journal 2023-12-27 Under Review 2024-01-15 minor revision 2024-01-16 Submitted to journal 2024-01-19 Submission accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2020-09-04 投稿 2020-09-10 with editor 2020-10-02 Under Review 2020-11-11 Major Revision 2021-02-01 大修返回去 2021-02-02 with editor 2021-02-24 Accept 两个审稿人，大约提了20个问题，许多都是我们当时刻意回避的，审稿人都提出来了，在大修中认真回答审稿人的问题，让做亚组分析就做亚组分析，不能补充的内容就实话实说，告知审稿人我们的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2023-11-22 ms5000001791427926 来自黑龙江省

作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？

27 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：投白血病相关的综述，2个审稿人，提的意见比较中肯，审稿速度很快 2023-11-23 投稿 2023-11-28 editor assigned 2023-11-29 Under Review 2023-12-12 Major revision 2023-12-26 Submitted to journal 2023-12-27 Under Review 2024-01-15 minor revision 2024-01-16 Submitted to journal 2024-01-19 Submission accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2020-09-04 投稿 2020-09-10 with editor 2020-10-02 Under Review 2020-11-11 Major Revision 2021-02-01 大修返回去 2021-02-02 with editor 2021-02-24 Accept 两个审稿人，大约提了20个问题，许多都是我们当时刻意回避的，审稿人都提出来了，在大修中认真回答审稿人的问题，让做亚组分析就做亚组分析，不能补充的内容就实话实说，告知审稿人我们的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2022-09-24 wylj

审稿结束状态一周还没给意见，是不是凶多吉少啊

79 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：投白血病相关的综述，2个审稿人，提的意见比较中肯，审稿速度很快 2023-11-23 投稿 2023-11-28 editor assigned 2023-11-29 Under Review 2023-12-12 Major revision 2023-12-26 Submitted to journal 2023-12-27 Under Review 2024-01-15 minor revision 2024-01-16 Submitted to journal 2024-01-19 Submission accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2020-09-04 投稿 2020-09-10 with editor 2020-10-02 Under Review 2020-11-11 Major Revision 2021-02-01 大修返回去 2021-02-02 with editor 2021-02-24 Accept 两个审稿人，大约提了20个问题，许多都是我们当时刻意回避的，审稿人都提出来了，在大修中认真回答审稿人的问题，让做亚组分析就做亚组分析，不能补充的内容就实话实说，告知审稿人我们的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2023-03-19 ms9000000180277427

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：hematology
经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收

72 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197970, encodeId=2f3a219e970d7, content=质量检查就10天了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bbb4799156, createdName=2606467171, createdTime=Thu Apr 11 13:43:26 CST 2024, time=2024-04-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183703, encodeId=792f2183e038c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：投白血病相关的综述，2个审稿人，提的意见比较中肯，审稿速度很快 2023-11-23 投稿 2023-11-28 editor assigned 2023-11-29 Under Review 2023-12-12 Major revision 2023-12-26 Submitted to journal 2023-12-27 Under Review 2024-01-15 minor revision 2024-01-16 Submitted to journal 2024-01-19 Submission accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=775c5640894, createdName=ms8000000428100640, createdTime=Wed Jan 24 16:20:42 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164043, encodeId=1dea21640439d, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;血液病 经验分享：根据投稿指南要求修改排版，表达准确，图表清晰度够，审稿快，通过率高 2023-08-31投稿 2023-09-05 with editor 2023-09-01 Under Review 2023-09-19 Major revise 2023-10-13 Submitted to journal 203-10-16 Under Review 2023-10-20 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Sat Oct 21 07:35:27 CST 2023, time=2023-10-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2125680, encodeId=4cce21256806c, content=2022.12.15投稿 2023.04.08 两个审稿人给了意见 2023.04.11修回 4.13接受编辑很客气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Apr 13 13:55:16 CST 2023, time=2023-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926986, encodeId=b5b192698693, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2020-09-04 投稿 2020-09-10 with editor 2020-10-02 Under Review 2020-11-11 Major Revision 2021-02-01 大修返回去 2021-02-02 with editor 2021-02-24 Accept 两个审稿人，大约提了20个问题，许多都是我们当时刻意回避的，审稿人都提出来了，在大修中认真回答审稿人的问题，让做亚组分析就做亚组分析，不能补充的内容就实话实说，告知审稿人我们的困难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLfmR4mafTv9yhHTykjCcGOQP5acHwbYj07fiaDoT6p8jxes2icO8n9R8BD8t0LJmg1SjlPiaqWZn33g/132, createdBy=5c971339316, createdName=bright120, createdTime=Wed Feb 24 23:39:35 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2090155, encodeId=c84a2090155e7, content=审稿结束状态一周还没给意见，是不是凶多吉少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Sat Sep 24 19:16:00 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120472, encodeId=137d21204e24f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：hematology 经验分享：2023-1-10 投稿 2023-3-11 大修 2023-3-17修回两天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d65c8353596, createdName=ms9000000180277427, createdTime=Sun Mar 19 19:24:51 CST 2023, time=2023-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196544, encodeId=6ced119654419, content=请问大家这个submitted to journal 的状态会持续多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20f5472731, createdName=ms8000001664151388, createdTime=Wed Feb 23 21:05:11 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2022-02-23 ms8000001664151388

请问大家这个submitted to journal 的状态会持续多长时间？

217 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务